SM
TEVA icon

Sabby Management’s Teva Pharmaceuticals TEVA Stock Holding History

Sabby Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,173
Closed -$247K – 402
2015
Q2 		$247K Buy
+4,173
New +$257K 0.01% 293
2014
Q3 		– Sell
-1,013,302
Closed -$53.7M – 291
2014
Q2 		$53.1M Buy
1,013,302
+648,561
+178% +$33.1M 2.28% 11
2014
Q1 		$19.3M Sell
364,741
-101,571
-22% -$4.69M 1.08% 22
2013
Q4 		$18.7M Buy
466,312
+437,709
+1,530% +$17.2M 1.19% 19
2013
Q3 		$1.08M Buy
28,603
+7,867
+38% +$307K 0.07% 117
2013
Q2 		$813K Buy
+20,736
New +$808K 0.05% 128

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sabby Management's TEVA Position: Q3 2015 in Review

Sabby Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 4,173 shares — an estimated $247K sold.

Sabby Management first reported a position in TEVA in Q2 2013 and held it in 6 quarters. The position peaked at $53.1M in Q2 2014. 824 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

  • Sabby Management reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Sabby Management sold 4,173 Teva Pharmaceuticals shares in Q3 2015, an estimated $247K.
  • Sabby Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Sabby Management's Teva Pharmaceuticals position peaked at $53.1M in Q2 2014.
  • 824 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Sabby Management's 13F filing for Q3 2015, filed 16 Nov 2015.